Email updates

Keep up to date with the latest news and content from JTM and BioMed Central.

Open Access Commentary

Tracking the impact of translational research in psychiatry: state of the art and perspectives

Rodrigo Machado-Vieira

Author Affiliations

Institute and Department of Psychiatry, Laboratory of Neuroscience, LIM27, University of Sao Paulo, Rua Ovidio Pires de Campos, 785, Sao Paulo, SP, Brazil

Journal of Translational Medicine 2012, 10:175  doi:10.1186/1479-5876-10-175

Published: 28 August 2012

Abstract

Personalized treatments have become a primary goal in translational psychiatric research. They include the identification of neural circuits associated with psychiatric disorders and definition of treatment according to individual characteristics. Many new tools and technologies have been developed but further efforts are required to provide clues on how these scientific advances in psychiatry may be translated into more effective therapeutic approaches. Obstacles to the progress of translational psychiatry also involve numerous scientific, financial, ethical, logistics and regulatory aspects. Also, the goal of DSM-5 to expand “signs and symptoms” classification to incorporate biological measures may help the development of new multifactorial and dimensional models able to better understand the pathophysiology of psychiatric disorders and develop improved treatments. Finally, a better understanding on the significant response variability, cognitive functioning, role of comorbidities and treatment-resistant cases are critical for the development of prevention and intervention strategies that are more effective.

Keywords:
Translational; Psychiatry; Personalized; Treatment; Human; Animal; Research; Biomarker